Xiaodong Wang, Director at BeiGene, Ltd. (BGNE), sold 131,237 shares at $223.00 ($29.7M) on 2023-03-08, disclosed to the SEC on 2023-03-10.
Open-market sale of $29.7M BGNE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $223.00 | 3,433 | $766K | 2.6% |
| 2 | $224.01 | 7,458 | $1.7M | 5.6% |
| 3 | $224.01 | 7,458 | $1.7M | 5.6% |
| 4 | $224.92 | 12,534 | $2.8M | 9.5% |
| 5 | $224.92 | 12,534 | $2.8M | 9.5% |
| 6 | $225.35 | 400 |
| $90K |
| 0.3% |
| 7 | $225.95 | 14,077 | $3.2M | 10.7% |
| 8 | $225.95 | 14,077 | $3.2M | 10.7% |
| 9 | $226.61 | 200 | $45K | 0.2% |
| 10 | $227.12 | 17,170 | $3.9M | 13.1% |
| 11 | $227.12 | 17,170 | $3.9M | 13.1% |
| 12 | $227.78 | 12,363 | $2.8M | 9.5% |
| 13 | $227.78 | 12,363 | $2.8M | 9.5% |
| Total | $226.11 avg | 131,237 | $29.7M | 100% |
| Filing → |
| ONC | SELL | 2025-06-25 | $668K | — | Filing → |
| ONC | SELL | 2025-06-12 | $21.9M | — | Filing → |
| BGNE | SELL | 2025-05-15 | $18.6M | — | Filing → |